Regulatory role of sympathetic nervous system-adrenergic receptor on bone remodeling

Zheng Zhou,Changming Zhao,Kai Jiao,Meiqing Wang
DOI: https://doi.org/10.7518/gjkq.2015.03.024
2015-01-01
Abstract:The?sympathetic?nervous?system(SNS)?of?reconstructed?bone?tissues?and?bone?cell?innervation?is?the?basis?in?regulating?bone?metabolism?in?histological?studies.?The?binding?of?adrenergic?receptor?and?its?corresponding?ligands?can?activate?multiple?signal?transduction?pathways,?complete?the?regulation?of?osteoblast?and?osteoclast?cells,?and?regulate?bone?metabolism. For osteoblasts, SNS can be activated by α1?receptors?to?promote?bone?formation?but?can?also?be?activated?by?β2?receptor?to?inhibit?bone?formation.?For?osteoclasts,?SNS?can?directly?affect?osteoclast?precursor?cells?and?promote?their?differentiation.?SNS?can?also?be?adjusted?with?a?pro-osteoclastic?factor?nuclear?factor?kappa?B?receptor?to?activate?secretion?of?bone?cells,?and?thus,?indirectly?promote?the?activity?of?osteoclasts.?In?the?physiology?and?pathology?of?bone?remodeling,?SNS?regulates?osteoclast?activity?in?the?alveolar?bones?under?mechanical?stimulation.?In?addition?to?the?occurrence?and?development?of?SNS?and?osteoporosis,?blocking?SNS?signals?to?prevent?osteoporosis?with?pathological?bone?loss?has?important?clinical?implications?to?characterize?the?disease.
What problem does this paper attempt to address?